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Patient Factors Associated With Appendectomy
Within 30 Days of Initiating Antibiotic Treatment for Appendicitis
Writing Group for the CODA Collaborative
Invited Commentary
IMPORTANCE Use of antibiotics for the treatment of appendicitis is safe and has been found
to be noninferior to appendectomy based on self-reported health status at 30 days.
Identifying patient characteristics associated with a greater likelihood of appendectomy
within 30 days in those who initiate antibiotics could support more individualized
decision-making.

Supplemental content

OBJECTIVE To assess patient factors associated with undergoing appendectomy

within 30 days of initiating antibiotics for appendicitis.
DESIGN, SETTING, AND PARTICIPANTS In this cohort study using data from the Comparison
of Outcomes of Antibiotic Drugs and Appendectomy (CODA) randomized clinical trial,
characteristics among patients who initiated antibiotics were compared between those who
did and did not undergo appendectomy within 30 days. The study was conducted at 25 US
medical centers; participants were enrolled between May 3, 2016, and February 5, 2020.
A total of 1552 participants with acute appendicitis were randomized to antibiotics (776
participants) or appendectomy (776 participants). Data were analyzed from September 2020
to July 2021.
EXPOSURES Appendectomy vs antibiotics.
MAIN OUTCOMES AND MEASURES Conditional logistic regression models were fit to estimate
associations between specific patient factors and the odds of undergoing appendectomy
within 30 days after initiating antibiotics. A sensitivity analysis was performed excluding
participants who underwent appendectomy within 30 days for nonclinical reasons.
RESULTS Of 776 participants initiating antibiotics (mean [SD] age, 38.3 [13.4] years;
286 [37%] women and 490 [63%] men), 735 participants had 30-day outcomes, including
154 participants (21%) who underwent appendectomy within 30 days. After adjustment for
other factors, female sex (odds ratio [OR], 1.53; 95% CI, 1.01-2.31), radiographic finding of
wider appendiceal diameter (OR per 1-mm increase, 1.09; 95% CI, 1.00-1.18), and presence
of appendicolith (OR, 1.99; 95% CI, 1.28-3.10) were associated with increased odds of
undergoing appendectomy within 30 days. Characteristics that are often associated with
increased risk of complications (eg, advanced age, comorbid conditions) and those clinicians
often use to describe appendicitis severity (eg, fever: OR, 1.28; 95% CI, 0.82-1.98) were not
associated with odds of 30-day appendectomy. The sensitivity analysis limited to
appendectomies performed for clinical reasons provided similar results regarding
appendicolith (adjusted OR, 2.41; 95% CI, 1.49-3.91).
CONCLUSIONS AND RELEVANCE This cohort study found that presence of an appendicolith was
associated with a nearly 2-fold increased risk of undergoing appendectomy within 30 days of
initiating antibiotics. Clinical characteristics often used to describe severity of appendicitis
were not associated with odds of 30-day appendectomy. This information may help guide
more individualized decision-making for people with appendicitis.
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or more than 120 years, appendectomy has been the
standard treatment for acute appendicitis. In the last 2
decades, 10 randomized clinical trials (RCTs)1-10 in adults
demonstrated that most patients who initiate antibiotic treatment can avoid appendectomy within 30 days. To support
decision-making in acute appendicitis, understanding the associations between clinical and radiographic characteristics
and the risk of 30-day appendectomy is critical.
While it has been suspected that more advanced appendicitis (eg, perforation) is associated with appendectomy after initiating antibiotics, the most commonly used staging system (American Association for the Surgery of Trauma [AAST])
is based on information that is neither available at the time of
decision-making for antibiotics (ie, pathologic findings) nor
very sensitive for perforation11 (ie, radiographic information). Other scoring systems (eg, Alvarado score) were designed to diagnose appendicitis rather than estimate the
response to antibiotics. It has been speculated that the presence of an appendicolith, ie, inspissated and mineralized stool,
may be associated with failure of antibiotics. While appendicolith is associated with perforation and complications after
appendectomy,12 patients with appendicolith have been excluded from all but 1 prior RCT5 evaluating antibiotics. Thus,
the association between appendicolith and avoidance of appendectomy in adults remains to be determined.
Among 776 participants randomized to antibiotics in the
recently reported Comparison of Outcomes of Antibiotic Drugs
and Appendectomy (CODA) trial (ClinicalTrials.gov identifier: NCT02800785),13 the 27% of participants with appendicolith had a higher rate of appendectomy by 90 days (time at
which all participants had follow-up at the time of publication) compared with those without appendicolith (41% vs 25%).
The degree to which appendicolith is a marker associated with
more advanced disease or is an independent risk factor for appendectomy was not assessed. Using data from the antibioticassigned participants in the CODA trial, we describe demographic characteristics, clinical appendicitis stage information,
and radiographic characteristics (AAST) among participants
who underwent appendectomy 30 days after randomization
to the antibiotics group compared with those who did not. Appendectomy at 30 days was selected as the end point of this
analysis to focus on initial treatment response and exclude recurrence. In a sensitivity analysis, we focused on only patients who had an appendectomy for acute clinical reasons.

Methods
The trial protocol of the CODA trial was approved by institutional review boards at all 25 participating sites. All participants provided written informed consent. This study is reported following the Strengthening the Reporting of
Observational Studies in Epidemiology (STROBE) reporting
guideline.

Data Set Description
The CODA trial was a nonblinded, noninferiority randomized
clinical trial designed to assess whether antibiotic treatment for
E2

Key Points
Question Which patient factors are associated with
appendectomy after starting antibiotics for acute appendicitis?
Findings This cohort study including 735 patients
with appendicitis initially treated with antibiotics found that
appendicitis severity was not associated with risk of
appendectomy within 30 days, but presence of appendicolith
was associated with a nearly 2-fold increased risk.
Meaning These findings suggest that for patients considering
antibiotics who want to better understand their chance of
appendectomy, assessing appendicolith status may be
informative.

appendicitis was noninferior to appendectomy. Patient stakeholders contributed to the design of the study, which is framed
to allow for differences in how patients prioritize outcomes.14,15
The trial was funded by the Patient-Centered Outcomes Research Institute. Complete details of the trial design and protocol have been published elsewhere.13,16 To help support appendicitis-related decision-making during the COVID-19
pandemic, the primary outcome analysis was published in
October 2020,13 earlier than planned, once all participants had
90-day follow-up information. In that report, 90-day appendectomy rates in the antibiotics-assigned group were presumed related to index appendicitis (≤30 days) or recurrence
(>30 days). The focus of this secondary data analysis is on appendectomy at 30 days in the antibiotics group of the CODA trial.
The study was conducted at 25 US medical centers participating in the Comparative Effectiveness Research Translation Network, which is based at the University of
Washington.17 Adult patients with a clinical diagnosis of uncomplicated appendicitis confirmed by imaging were approached consecutively in emergency departments by research coordinators. Study exclusion criteria have been
described previously.13,16 Participants were enrolled between
May 3, 2016, and February 5, 2020. Both treatments in the
CODA trial have been previously described.13

Outcome Measure
Appendectomy at 30 days is defined as appendectomy within
30 days of randomization (confirmed by participant survey).
Participants were designated lost to follow-up (missing) if they
did not respond to the 30-day and 90-day surveys, did not report an appendectomy on a prior survey, and did not have a
record of appendectomy in their health record. When the participant reported having an appendectomy at a hospital other
than the one from their index visit and did not provide a date
of operation, the median time between the 2 most recent surveys was used to estimate the date of appendectomy. The reason for appendectomy was classified using information from
the participant collected via scheduled surveys and from the
participant’s health record review provided by the site. Reasons were grouped into 3 general categories: acute clinical
(ie, development of diffuse peritonitis or worsening pain),
nonacute clinical (eg, clinician concern for mucocele),
and nonclinical (eg, participant concern for recurrence).
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Patient Factors
Our analysis considered key demographic, clinical, physiological, and radiologic variables (eTable 1 in Supplement 1). Factors were first characterized individually in their association
with 30-day appendectomy and then grouped into 3 sets:
physiologic, including demographic data (eg, age, sex, body
mass index [BMI; calculated as weight in kilograms divided by
height in meters squared], duration of symptoms, mean pain
score in the previous 7 days, white blood cell count, fever, and
nausea, vomiting, or anorexia); radiologic, including appendiceal diameter and abscess, perforation, or fat stranding; and
presence or absence of an appendicolith. Race and ethnicity
were determined by participant self-report, supplemented by
the electronic medical record when missing, at the time of enrollment. Along with health literacy, poverty, and language,
previous literature suggests race and ethnicity can be barriers to health care. Our focused list of individual factors reflects our effort to evaluate as many candidate factors as possible while recognizing both the limitations owing to the overall
number of appendectomies and the missingness and frequency
of responses for any factor. Furthermore, we also reduced repetition of measurements that reflect similar constructs and
therefore may be collinear; for example, we included just 1 pain
score from many available. We grouped the physiologic factors together, as these are readily available at presentation and
may be associated with the appendectomy outcome through
a biological pathway involving disease severity. We then explored the relative association of appendicolith, first evaluating physiologic factors, then including other radiologic
features, such as appendiceal width and signs of perforation
or severe phlegmon. The CODA data set for this analysis includes all information as of December 14, 2020.

Statistical Analysis
Baseline demographic and clinical characteristics of participants randomized to antibiotics were described using mean
and SD for continuous measures and number and percentage
for categorical variables. Characteristics are also summarized
overall and by outcome status: appendectomy at 30 days vs
no appendectomy within 30 days. To assess variation in appendectomy across practice sites, we plotted the proportion
of patients who underwent appendectomy at each site. The frequencies and percentages of each reason for appendectomy
were also tabulated.
Given the observed variation across sites in the proportion of participants undergoing appendectomy, we used
conditional logistic regression to focus on patient factors while
addressing site-level variables in both univariate and multivariable models of appendectomy status (appendectomy at 30
days vs no appendectomy within 30 days). The largest contributing site recruited 15% of the cohort, and sites with fewer
than 20 randomized participants were grouped together or with
another geographically similar site if one was available. Four
multivariable models were fit to assess the relative associations of appendicolith and other radiologic findings with appendectomy. The base model included age, sex, BMI, duration of symptoms, mean pain score, white blood cell count,
fever, and report of nausea, vomiting, or anorexia. The base + A

Original Investigation Research

model added appendicolith to the base model. The base + R
model included all variables in the base model and the radiologic features of appendiceal diameter and evidence of perforation, abscess, or fat stranding. The base + R + A model was
the full model that included the physiologic variables from the
base model, appendicolith, and all other radiologic variables.
Nested models were compared using a multivariate Wald test,18
with α set at .05.
Missing data on appendectomy status at 30 days and any
candidate factors were imputed using multivariate imputation by chained equations algorithms in R software versions
3.6.1 and 4.0.3 (R Project for Statistical Computing). All variables included in the full base + R + A model were included in
the imputation process, as well as the outcome and other
participant-reported variables and variables from health records collected at index. A full list of variables used for imputation is provided in eAppendix 1 in Supplement 1. Model coefficients were pooled across the 10 imputation sets and are
shown with corresponding 95% CIs. A planned sensitivity
analysis repeated the process of comparing 4 nested models
but examined appendectomy for acute clinical reasons, excluding appendectomies that were performed for nonclinical
or nonacute clinical reasons.
Finally, because conditional logistic regression adjusted for
site without actually quantifying site associations, we performed a post hoc assessment of the association of site after
controlling for all patient factors in the full model. To assess
variability across sites, we fit a mixed-effects logistic regression model treating site as a random effect and performing a
variance component test (ie, testing the SD of the random site
effect equal to vs >0) pooling over imputed data sets. 19
All analyses were performed in R statistical software versions
3.6.1 and 4.0.3. P values were 2-sided, and statistical significance was set at α = .05. Data were analyzed from September
2020 to July 2021.

Results
Of 776 participants (mean [SD] age, 38.3 [13.4] years; 286
[37%] women and 490 [63%] men) randomized to antibiotics, 30-day appendectomy status was available for 735 participants (95%); 154 participants (21%) underwent appendectomy within 30 days. Among sites randomizing at least 20
participants, frequency of appendectomy at 30 days ranged
from 8% to 35% (Figure). Participant sociodemographic and
clinical characteristics at the time of enrollment are described in Table 1. Appendicolith was found in 212 participants (27%) overall, in 65 participants (42%) who underwent
appendectomy within 30 days, and in 138 participants (24%)
who did not have an operation.
The reported reason for appendectomy was most often an
acute clinical reason (116 participants [77%]), with worsening
signs and symptoms of appendicitis being the most common
reason given for undergoing surgical treatment (Table 2).
Among those who had an appendectomy for nonclinical reasons, participant worry or concern for recurrence and consultation with friend or family were the most frequent motiva-
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Figure. Unadjusted Proportion of Participants With Appendectomy
Within 30 Days by Practice Site
Site n
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y

112
82
71
73
57
54
44
31
31
24
22
21
20
18
13
12
8
9
8
5
6
5
4
3
2
0

0.25

0.50

0.75

1.00

Proportion with appendectomy in 30 d

Only participants with known appendectomy status at 30 days were included in
these proportions. Practice sites were deidentified and ordered by number
randomized to antibiotics, such that the highest enrolling site is listed at the top
and the lowest enrolling is at the bottom. Larger squares indicate sites with
more patients randomized to antibiotics; squares, proportion; and whiskers,
95% CI.

tions for surgical treatment (Table 2). Negative appendectomy
(without pathological evidence of acute appendicitis) was
uncommon, occurring in 4% (95% CI, 2%-9%) of patients but
occurred more often in women (8% [95% CI, 3%-18%] of women) than in men (1% [95% CI, 0%-6%] of men).
To create a more parsimonious multivariable model,
since BMIs of 25 to 30 and 30 to 35 had similar associations
with 30-day appendectomy (Table 1), we grouped BMI 25 to
35 together. In univariate models (Table 3), BMI of 25 to 35 vs
less than 25 was associated with increased odds of appendectomy (odds ratio [OR], 1.77; 95% CI, 1.14-2.75). BMI greater than
35 was associated with lower odds of appendectomy
compared with BMI less than 25 (OR, 0.75; 95% CI, 0.421.34). Appendiceal diameter (OR per 1-mm increase, 1.14;
95% CI, 1.06-1.22) and presence of appendicolith (OR, 2.56;
95% CI, 1.73-3.79) were also associated with increased odds
of appendectomy.
Model comparison of base + A vs base was statistically significant (pooled Wald test = 17.1; P < .001), indicating that the
inclusion of appendicolith status improved model fit (eTable 1
in Supplement 1). The full model (base + R + A) had improved model fit compared with the model that included all
variables except appendicolith (base + R, pooled Wald
test = 9.5; P = .003), suggesting that appendicolith status
provides more information about who was at risk of an appendectomy in 30 days beyond that already accounted for by
appendiceal diameter and evidence of perforation, abscess, or
fat stranding (Table 3 and eTable 1 in Supplement 1).
E4

In the full model, several factors were associated with increased odds of 30-day appendectomy after controlling for
other physiologic and radiologic factors: female sex (OR, 1.53;
95% CI, 1.01-2.31), increased appendiceal diameter (OR per
1-mm increase, 1.09; 95% CI, 1.00-1.18), and presence of appendicolith (OR, 1.99; 95% CI, 1.28-3.10) (Table 3). Characteristics that are often associated with increased risk of complications (eg, advanced age, comorbid conditions) and those
clinicians often use to describe appendicitis severity (eg, fever: OR, 1.28; 95% CI, 0.82-1.98) were not associated with odds
of 30-day appendectomy. The ORs for BMI 25 to 35 vs less than
25 and mean pain score in the previous 7 days were greater
than 1.00, but 95% CI lower bounds were less than 1.00 (BMI:
OR, 1.60; 95% CI, 0.99-1.60; pain score: OR, 1.03; 95% CI, 0.991.14). ORs from the base, base + A, and base + R models are
shown in eTable 2 in Supplement 1. We performed an exploratory, post hoc analysis that added an interaction term between appendiceal diameter and appendicolith to the full
model. This coefficient was not statistically significant (OR,
0.96; 95% CI, 0.82-1.11).
The planned sensitivity analysis of appendectomy performed for clinical reasons vs no appendectomy within 30
days produced similar results (eTable 3 in Supplement 1).
Notably, the association of appendicolith status with 30-day
appendectomy strengthened (OR, 2.41; 95% CI, 1.49-3.91).
Both model comparisons remained statistically significant (base + A vs base, pooled Wald test = 23.1; P < .001;
base + R + A vs base + R, pooled Wald test = 13.0; P < .001)
(eTable 1 in Supplement 1). Finally, the variance component
test from the mixed-effects model was statistically significant (D2, 7.9; P = .003), indicating that, after controlling for
physiologic and radiologic patient factors, the odds of
appendectomy still varied across sites.

Discussion
This cohort study using data from the CODA trial found a significant and persistent association between radiographic
evidence of an appendicolith and 30-day appendectomy in
participants initiating antibiotics (a nearly 2-fold increase in
odds), even after controlling for physiologic characteristics
and other radiographic findings. Of note, several factors
often presumed by clinicians to be consistent with more
severe appendicitis (ie, fever, higher white blood cell count,
and radiographic evidence of perforation) were not independently associated with appendectomy, but ORs were in the
expected direction. For more than a century, 20 surgeons
have looked for patient characteristics to help guide the
treatment of appendicitis. Increasing evidence that antibiotics can be used to treat appendicitis has made the search
for such factors even more relevant. Understanding which
patients are at higher risk of appendectomy after starting
antibiotics might be one way to guide treatment decisions.
An emerging theory proposes that appendicitis has 2
phenotypes,21 a simple type and a severe type, and that the first
does not necessarily evolve to the second if left untreated. The
simple type is thought likely to respond to antibiotics22 and
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Table 1. Demographic and Clinical Characteristics of Participants
Randomized to Antibiotics by Appendectomy Status at 30 Days
No. (%)a

Original Investigation Research

Table 1. Demographic and Clinical Characteristics of Participants
Randomized to Antibiotics by Appendectomy Status
at 30 Days (continued)
No. (%)a

Underwent
appendectomy
within 30 d
Characteristic

Overall
(n = 776)

Underwent
appendectomy
within 30 d

Yes
No
(n = 154) (n = 581)

Mean (SD)

38.3 (13.4)

38.8
(13.7)

38.0
(13.2)

≥50

150 (19)

32 (21)

104 (18)

<50

626 (81)

122 (79)

477 (82)

Female

286 (37)

61 (40)

211 (36)

Male

490 (63)

93 (60)

370 (64)

None or NR

134 (17)

32 (21)

97 (17)

Reported

641 (83)

122 (79)

483 (83)

Computed tomography alone

626 (81)

124 (81)

468 (81)

Ultrasonography alone

24 (3)

6 (4)

18 (3)

>1 imaging test

125 (16)

23 (15)

95 (16)

American Indian or Alaska Native

13 (2)

4 (3)

6 (1)

Magnetic resonance imaging

1 (<1)

1 (1)

0 (0)

Asian

39 (5)

10 (6)

29 (5)

Black

75 (10)

16 (11)

58 (10)

None or NR

564 (73)

89 (58)

443 (76)

Reported

212 (27)

65 (42)

Native Hawaiian or Pacific Islander

4 (1)

1 (1)

2 (<1)

138 (24)

11.5 (2.9)

12.3
(3.1)

11.3 (2.8)

None or NR

646 (86)

123 (84)

487 (87)

Reported

102 (14)

24 (16)

73 (13)

Imaging test

Race

White

461 (60)

79 (52)

359 (63)

Multiple or otherb

176 (23)

43 (28)

120 (21)

No

414 (53)

77 (50)

321 (55)

Yes

362 (47)

77 (50)

260 (45)

Appendicolith

Appendiceal diameter, mean (SD), mm
Perforation, abscess, or appendiceal fat
stranding present

Hispanic

Abbreviations: BMI, body mass index (calculated as weight in kilograms divided
by height in meters squared); NR, not reported.

Preferred language
English

538 (69)

103 (67)

410 (71)

Spanish

238 (31)

51 (33)

171 (29)

SI conversion factor: To convert white blood cells to ×109/L, multiply by 0.001.
a

For 41 participants, appendectomy status at 30 days was unknown.
These participants are included in the overall data only. Missing data for other
characteristics were race, 8 participants; health literacy help, 27 participants;
federal poverty level or Medicaid status, 188 participants; modified Charlson
comorbidity score, 3 participants; BMI, 174 participants; Alvarado score,
38 participants; duration of symptoms, 1 participant; pain in the last 7 days,
21 participants; white blood cell count, 3 participants; nausea, vomiting,
or anorexia, 1 participant; appendiceal diameter, 103 participants; and
perforation, 28 participants.

b

The most common response for other race was Hispanic.

Health literacy help
Never or rarely

608 (81)

115 (76)

466 (83)

Sometimes or more

141 (19)

36 (24)

93 (17)

No

217 (29)

37 (24)

168 (30)

Yes

545 (72)

116 (76)

402 (71)

Worried about bills

Below federal poverty level or
Medicaid beneficiary
No

315 (54)

54 (47)

Yes

273 (46)

61 (53)

190 (43)

0.2 (0.5)

0.3 (0.7)

0.2 (0.5)

251 (57)

<25

178 (30)

35 (25)

138 (32)

25-<30

198 (33)

51 (36)

132 (31)

30-<35

128 (21)

35 (25)

85 (20)

≥35

98 (16)

19 (14)

77 (18)

6.6 (1.6)

7.0 (1.5)

6.5 (1.6)

<1

195 (25)

39 (26)

145 (25)

≥1

580 (75)

114 (75)

436 (75)

Pain in previous 7 d, mean (SD)

5.4 (3.0)

5.9 (3.2)

5.3 (2.9)

White blood cell count, mean (SD), /μL

12 900
(4000)

13 500
(3900)

12 800
(4000)

None or NR

582 (75)

108 (70)

443 (76)

Reported

194 (25)

46 (30)

138 (24)

BMI

Alvarado score, mean (SD)

Yes
No
(n = 154) (n = 581)

Nausea, vomiting, or anorexia

Sex

Modified Charlson comorbidity score,
mean (SD)

Overall
(n = 776)

Characteristic

Age, y

Duration of symptoms, d

Fever

(continued)

may even be self-limiting.23-25 The severe type is thought to
be associated with perforation on presentation and less likely
to resolve successfully with antibiotics. Given the limited exclusion criteria in the CODA trial, it is likely that patients with
both types of appendicitis were included in the study. Unfortunately, while the 2-phenotype theory may have merit, we
did not identify any disease severity characteristics that were
associated with appendectomy at 30 days.
Appendicolith was the main factor we found to be associated with 30-day appendectomy. While we found that the
odds of appendectomy were approximately 2-fold higher for
those with an appendicolith compared with those without (unadjusted rates of 42% vs 24%), approximately 6 of 10 patients
with appendicolith did not undergo appendectomy within 30
days. For many individuals, appendicoliths are incidental findings, identified by computed tomography (CT) and autopsy
series in a variable proportion (4%-25%) of those without
appendicitis.26-28 In other patients, appendicolith may be a
marker or even a cause of more severe appendicitis.29,30 Most
of what we know about the success of antibiotics in patients
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Table 2. Primary Reason for Appendectomy Among Participants
Who Had an Appendectomy Within 30 Days

Table 3. Factors Associated With 30-Day Appendectomy in Univariate
and Multivariable Models

Reason

No (%) (n = 150)a

Acute clinical

116 (77)

Factor

Univariate

Base + R + A

88 (59)

Age, per 1-y increase

1.01 (0.99-1.02)

1.00 (0.98-1.01)

Female sex (vs male sex)

1.16 (0.80-1.68)

1.53 (1.01-2.31)

1.60 (0.99-2.60)

Worsening of symptoms

Odds ratio (95% CI)a

Continuing symptoms
≤48 h
>48 h

b

10 (7)

25-35

1.77 (1.14-2.75)

2 (1)

>35

0.75 (0.42-1.34)

0.68 (0.37-1.24)

Nonclinical

32 (21)

Symptoms duration ≥1 d (vs <1 d)

0.89 (0.58-1.36)

0.81 (0.51-1.31)

Worry or concern for recurrence

10 (7)

1.06 (0.99-1.14)

3 (2)

Mean pain in the previous 7 d,
per 1-point increase

1.07 (1.00-1.14)

Planned interval appendectomy
Consultation with friend or family

9 (6)

White blood cell count,
per 1000-cells/μL increase

1.04 (0.99-1.09)

1.03 (0.98-1.09)

b

Feverb

1.31 (0.87-1.97)

1.28 (0.82-1.98)

Includes participants who provided reason for appendectomy. For 4
participants, we were unable to determine if the reason for appendectomy
was clinical or nonclinical.

Nausea, vomiting, or anorexiab

0.83 (0.52-1.32)

0.69 (0.42-1.16)

Appendiceal diameter, per 1-mm
increase

1.14 (1.06-1.22)

1.09 (1.00-1.18)

Includes changed mind (2 participants), clinical team mistook assignment for
surgical treatment (1 participant), participant was struggling with swallowing
pills (1 participant), and personal preference or unknown (6 participants).

Perforation, abscess,
or fat strandingb

1.56 (0.94-2.59)

1.14 (0.66-1.98)

Appendicolithb

2.56 (1.73-3.79)

1.99 (1.28-3.10)

10 (7)

with appendicolith comes from the pediatric population. Although patients with appendicolith are often excluded from
pediatric trials,31 a few RCTs have included pediatric patients
with appendicolith, and a 2017 meta-analysis of these
patients32 found a much lower likelihood of response. Among
adults, only 1 RCT of antibiotics and appendectomy, by Vons
et al,5 included patients with appendicolith in the antibioticsassigned group. In that study, 6 of 19 patients (32%) did not
have resolution of appendicitis within a month and underwent appendectomy, a rate very similar to that seen in CODA
participants with an appendicolith (31%).13 Another challenge in assessing the role of appendicolith and appendectomy is that surgeons were not blinded in the CODA trial or the
study by Vons et al5; their beliefs about appendicolith may also
play a role in the greater use of appendectomy in that group.
The nearly 2-fold increased odds of appendectomy
among people with an appendicolith suggest that, at least
for patients interested in the antibiotic treatment option,
obtaining information about appendicolith status may be
important. For those patients, given the presumed role of
imaging in identifying appendicolith, using CT instead of
ultrasonography as part of the diagnostic evaluation for
appendicitis may be a better alternative.33 While CT was
used for diagnosis in 97% of participants in the CODA trial,
ultrasonography may be more widely in use across the
United States and globally.34 The use of CT for this purpose
needs to be balanced against the low sensitivity of CT in
identifying appendicolith (55%) found in a study by Singh
and Mariadason,12 as well as increased radiation exposure.35
Furthermore, knowledge of an appendicolith may or may
not influence decision-making. When determining treatment in light of an appendicolith, clinicians and patients
should consider the risk of appendectomy in the context of
several outcomes, such as overall well-being, time until
relief of symptoms, time in health care, safety events, and
time away from work—all parameters for which appendicoE6

BMI (vs <25)

Nonacute clinical

Other
a

18 (12)

Abbreviation: BMI, body mass index (calculated as weight in kilograms divided
by height in meters squared).
SI conversion factor: To convert white blood cells to ×109/L, multiply by 0.001.
a

All odds ratios are pooled estimates from multiple imputed data sets, adjusted
for site. The base + R + A (full model) includes all variables listed.

b

Compared with none or not reported.

lith was associated with worse outcomes, albeit with low frequencies of events.13,36 For some patients, this added risk
may make antibiotics a less attractive option, while for others, these risks may be outweighed by the benefits of potentially avoiding an urgent operation. Interestingly, patient
advisor feedback during the design phase of the CODA trial
indicated that some patients would find antibiotics to be a
preferable alternative even if they were in a subgroup with
an up to 75% chance of appendectomy after antibiotics.
An unexpected finding in the adjusted analysis was an
association of female sex and appendectomy, an observation
not identified on univariate analysis or in the sensitivity analysis limited to appendectomies with clinical indication. In considering associations between sex and clinical outcomes,37
there is robust debate about potential pathways, such as biological, social, or other, that may be involved. The CODA trial
did not include data that might inform this question; therefore, we caution against applying this finding in clinical decision-making. Women were more likely to have a negative appendectomy. This finding may also be associated with factors
that we could not or did not study, such as misdiagnosis at index admission, adequacy of pain control, concerns about the
impact of appendicitis on fertility, or prior experiences with
the health care system that could have influenced the 5 participants’ decision to undergo appendectomy. Underrecognition and undertreatment of acute abdominal pain in women38
may also have been a factor.
After adjusting for physiologic and radiologic factors, there
remained important variation across enrollment sites in the
rate of appendectomy after initiating antibiotic treatment.
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The reasons for this variation are unclear and may be related
to process (eg, pain control, encouragement from staff and clinicians) as well as structural issues (eg, ease of reentering the
health care system with concerns or complaints, availability
of telephone-based support); these highlight the relative complexity of the antibiotic treatment intervention. Individual
bias from clinicians and patients and experience and comfort
with nonoperative treatment that varies by site may also play
a role for this observation. To counter the risk of clinician bias
and the potential for undue influence,39 evidence-based shared
decision-making processes have emerged as a standard.40

Limitations
This study had several limitations. Most critically, we were not
able to discern which appendectomies were a consequence of
a failure of antibiotics vs other unmeasured reasons, such as
insufficient pain control. While our sensitivity analysis attempted to focus on appendectomies owing to physiologic failure, participants often voiced multiple reasons for undergoing appendectomy, and it was difficult to determine if the
participant was requesting the treatment solely owing to their
symptoms or if they were also influenced by the preferences
of their treating clinician. Similarly, we chose a 30-day window rather than a 90-day window to focus on the index case
of appendicitis; however, we cannot rule out recurrence within
this timeframe. Generalizability of findings is another limitation: this study may only be relevant to those without CODA
exclusion criteria (eg, abscess and severe phlegmon) and those
who undergo a CT scan to determine appendicolith status. We
also did not power this study to assess this outcome or these
specific factors. Owing to low prevalence, we combined perforation, abscess, and phlegmon into 1 variable, which may
have obscured the individual risk associated with 1 or more of
these features. Furthermore, while we did select candidate
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factors with the intention of avoiding correlated variables, multicollinearity may still be attenuating the strength of some findings. We chose not to use a dimension-reduction procedure,
such as factor analysis, as this would limit our ability to see the
risk associated with each individual characteristic; however,
doing so would have allowed the inclusion of more factors. We
also did not include demographic variables in the nested model
analysis that could be seen as barriers to health care, as it was
impossible to know if the barrier was preventing a participant
from getting a needed appendectomy or pushing them to get
an appendectomy that was not required or desired by the participant. We instead focused on likely biological pathways that
might be associated with a patient undergoing appendectomy. Additionally, these are exploratory models that should
not be used for any given patient. Cohorts with different inclusion and exclusion criteria and more detailed information
on the reason for appendectomy are needed to confirm these
findings.

Conclusion
This cohort study found that the presence of appendicolith
was associated with the greatest risk for undergoing appendectomy within 30 days of initiating antibiotics, among examined factors. Multiple factors that clinicians associate with
disease severity were not independently associated with appendectomy. Beyond these factors, site characteristics, potentially including physician decision-making and unmeasured processes of care and structural barriers, may also be
involved in determining which patients get an appendectomy. These findings may be helpful in developing patientfacing tools to support informed decision-making in the treatment of appendicitis.
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